All Stories

  1. High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah’s Witnesses patients: a feasible option in the age of hematopoietic growth factors

    Article • Leukemia & Lymphoma, February 2019, Taylor & Francis

    Louis Pérol

  2. Loss of immune tolerance to IL-2 in type 1 diabetes

    Article • Nature Communications, October 2016, Springer Science + Business Media

    Louis Pérol

  3. New Molecular and Cellular Mechanisms of Tolerance: Tolerogenic Actions of IL-2

    Article • January 2016, Springer Science + Business Media

    Louis Pérol

  4. Heterogeneous CD3 Expression Levels in Differing T Cell Subsets Correlate with the In Vivo Anti-CD3–Mediated T Cell Modulation

    Article • The Journal of Immunology, February 2015, The American Association of Immunologists

    Nicolas Cagnard, Louis Pérol

  5. Potential limitations of IL-2 administration for the treatment of experimental acute graft-versus-host disease

    Article • Immunology Letters, December 2014, Elsevier

    Louis Pérol

  6. Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes

    Article • Diabetes, May 2013, American Diabetes Association

    Nicolas Cagnard, Louis Pérol

  7. Role of Cytokines in Thymus- Versus Peripherally Derived-Regulatory T Cell Differentiation and Function

    Article • Frontiers in Immunology, January 2013, Frontiers

    Louis Pérol